CAR-T therapy has proven effective for some blood cancers. New research by Jonathan S. Serody, MD, and colleagues suggests ways to use it effectively to attack solid tumors.
Jenny Ting, PhD, and colleagues published a study showing bacteria mitigated radiation exposure and enhanced the recovery of blood cell production as well as repair of the gastrointestinal tract.
CAR-T immunotherapy has been used to treat Hodgkin lymphoma with remarkable success for the first time, according to the results of an early phase clinical trial.
Jared Weiss, MD, and Ben Vincent, MD, are leading an upcoming clinical trial hoping to cure lung and head and neck squamous cell carcinomas with their PANDA-VAC therapy.
An investigational therapy for Hodgkin lymphoma received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.
Yuliya Pylayeva-Gupta, PhD, and Paul Dayton, PhD, are studying whether they can use tiny, engineered microbubbles and ultrasound imaging to improve the activation of the immune system against pancreatic cancer, one of the deadliest cancers.
Researchers led by Yuliya Pylayeva-Gupta, PhD, have identified the culprit that keeps cancer-killing immune cells from reaching pancreatic cancer tumors. Their findings were published in the journal Cancer Immunology Research.
Tumors can create a hostile environment for cancer-fighting immune cells. In a new study, University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a method for engineering immune cells to improve their survival and proliferation, even within a hostile tumor. Researchers led by UNC Lineberger’s Gianpietro Dotti, MD, report in the journal Nature … Continued
